C-Mer Eye Care Holdings (HKSE:03309) Valuation Rank

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

C-Mer Eye Care Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you